NAIROBI/DAKAR – The World Health Organization (WHO), Wednesday said that the only vaccine for malaria must be broadly used in Africa. This could represent a huge step towards a devastating disease that claims hundreds of thousands annually.
RTS,S or Mosquirix is the recommended vaccine. This was developed by GlaxoSmithKline, an American drugmaker (NYSE:). The WHO’s two top immunization advisory groups, Malaria Policy Advisory Group (NYSE:) and Strategic Advisory Group of Experts on Immunization (WHO:), jointly announced the decision in Geneva.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.